Andrew Kellum
Hematology & Oncology · Tupelo, MSNPI 1427055185
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $619 and has fallen 94.4% since, to $35 in 2024. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 131 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacyclics LLC, An Abbvie Company$238
- Pfizer$164
- Amgen$161
- GSK$158
- Merck$128
- E.r. Squibb & Sons, L.L.C.$126
- plus $1K from 31 others
Across 22 payments — averaging $7678.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$152K
- F. Hoffmann-la Roche AG$9K
- Genentech, Inc.$6K
- Puma Biotechnology, Inc.$2K
What the payments were for
- Food & beverage$2,01897%
- Education$643%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | 13 | $238 |
| Pfizer | 13 | $164 |
| Amgen | 9 | $161 |
| GSK | 11 | $158 |
| Merck | 8 | $128 |
| E.r. Squibb & Sons, L.L.C. | 9 | $126 |
| Johnson & Johnson | 8 | $112 |
| Seagen Inc. | 7 | $99 |
| Genentech USA, Inc. | 3 | $92 |
| AstraZeneca | 4 | $73 |
| Sanofi | 3 | $63 |
| Novartis | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| AbbVie | 3 | $49 |
| Bristol Myers Squibb | 3 | $45 |
| Exelixis Inc. | 3 | $41 |
| Gilead | 2 | $39 |
| Coherus Oncology, Inc. | 3 | $39 |
| Eisai Inc. | 2 | $28 |
| Incyte Corporation | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Beigene USA, Inc. | 1 | $20 |
| Biocompatibles, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Acceleron Pharma, Inc. | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $15 |
| Secura Bio, Inc. | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Verastem, Inc. | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
| Tesaro, Inc. | 1 | $12 |
| Agios Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,082 in reported general payments places this provider in the 10th percentile of 57 hematology & oncology providers in Mississippi.
Other hematology & oncology in Tupelo
- Paschal WilsonTupelo$7K
- Charles MontgomeryTupelo$6K
- Julian HillTupelo$3K
- Amit JainTupelo$3K
- Rana UsmanTupelo$3K
- Solly ChedidPascagoula$1.7M
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.